🔎 Trials Near Me

Hjem › Hjertesvigt › Californien › San Francisco

Hjertesvigt kliniske forsøg i San Francisco, CA

29 studier for Hjertesvigt søger deltagere på steder i og omkring San Francisco (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.

Officiel studietekst (engelsk)

Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →

ELEVATE-HFpEF Clinical Study

Rekrutterer
  • Sutter Health Hospital, San Francisco
Alder 40 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT06678841

Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function

RekruttererFase 3
  • Research Site, San Francisco
Alder 18 til 130 · Alle køn · Opdateret 2. okt. 2026 · NCT06307652

A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy

RekruttererFase 2
  • University of California, San Francisco, San Francisco
  • University of California San Francisco UCSF, San Francisco
Alder 40 til 84 · Alle køn · Opdateret 30. sep. 2026 · NCT06979362

Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction

RekruttererFase 3
  • California Pacific Medical Center Van Ness Campus, San Francisco
Alder 18 til 85 · Alle køn · Opdateret 24. sep. 2026 · NCT06736574

Alleviant ALLAY-HFrEF Study

Rekrutterer
  • University of California San Francisco, San Francisco
Alder 18 og opefter · Alle køn · Opdateret 16. sep. 2026 · NCT06812533

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

RekruttererFase 3
  • Kaiser Permanente, San Francisco
Alder 18 til 99 · Alle køn · Opdateret 16. sep. 2026 · NCT07037459

Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin

RekruttererFase 3
  • Research Site, San Francisco
Alder 40 og opefter · Alle køn · Opdateret 15. sep. 2026 · NCT06677060

A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)

RekruttererFase 3
  • San Francisco, CA Investigative Site CON-10315, San Francisco
  • CON-10023, San Francisco, CA, San Francisco
Alder 18 og opefter · Alle køn · Opdateret 10. sep. 2026 · NCT06024746

A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients

RekruttererFase 3
  • San Francisco, CA Investigative Site 10023, San Francisco
Alder 18 og opefter · Alle køn · Opdateret 10. sep. 2026 · NCT06008197

Remote Dielectric Sensing (ReDS) Assisted Diuresis in Acute Decompensated Heart Failure

Rekrutterer
  • University of California, San Francisco, San Francisco
Alder 18 og opefter · Alle køn · Opdateret 2. sep. 2026 · NCT03586336

AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF

RekruttererFase 2
  • University of California, San Francisco - Heart and Vascular Center, San Francisco
Alder 40 til 85 · Alle køn · Opdateret 27. aug. 2026 · NCT06793371

Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure

Rekrutterer
  • Zuckerberg San Francisco General, San Francisco
  • University of California San Francisco, San Francisco
Alder 21 og opefter · Alle køn · Opdateret 25. aug. 2026 · NCT05677100

A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)

RekruttererObservationsstudie
  • University Of California San Francisco Medical Center, San Francisco
Alder 18 og opefter · Alle køn · Opdateret 19. aug. 2026 · NCT05489705

LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2

RekruttererFase 3
  • Tenax Investigational Site, San Francisco
Alder 18 til 85 · Alle køn · Opdateret 19. aug. 2026 · NCT07288398

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

RekruttererFase 3
  • Kaiser Permanente Northern California, San Francisco
  • San Francisco V.A. Medical Center, San Francisco
Alder 18 og opefter · Alle køn · Opdateret 18. aug. 2026 · NCT07567001

Alleviant ALLAY-HF Study

Rekrutterer
  • University of California San Francisco, San Francisco
Alder 40 og opefter · Alle køn · Opdateret 14. aug. 2026 · NCT05685303

Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia

RekruttererFase 3
  • UC San Francisco Medical Center, San Francisco
Alder 2 til 11 · Alle køn · Opdateret 24. jul. 2026 · NCT06597006

A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists

RekruttererFase 3
  • San Francisco, CA Investigative Site FIN-10023, San Francisco
Alder 18 og opefter · Alle køn · Opdateret 10. jul. 2026 · NCT06033950

PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III

Rekrutterer
  • UCSF Medical Center, San Francisco
Alder 18 og opefter · Alle køn · Opdateret 29. jun. 2026 · NCT05934487

Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure

Rekrutterer
  • University of California at San Francisco, San Francisco
Alder 18 og opefter · Alle køn · Opdateret 10. jun. 2026 · NCT06526195

Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia

RekruttererFase 3
  • UC San Francisco Medical Center, San Francisco
  • UC San Francisco Medical Center, San Francisco
Alder 6 til 11 · Alle køn · Opdateret 15. maj 2026 · NCT06597019

Developing a Digital Aid to Improve ICD Decisions

Rekrutterer
  • University of California, San Francisco, San Francisco
Alder 60 og opefter · Alle køn · Opdateret 27. apr. 2026 · NCT07084142

The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR

Rekrutterer
  • University of California- San Francisco, San Francisco
Alder 18 og opefter · Alle køn · Opdateret 13. apr. 2026 · NCT03142152

Voice Analysis to Detect Pulmonary Arterial Pressure Changes in Heart Failure

RekruttererObservationsstudie
  • University of California, San Francisco (UCSF), San Francisco
Alder 18 og opefter · Alle køn · Opdateret 2. mar. 2026 · NCT07443670

Human/Machine Interface: What the HeartMate 3 ® Device Tells Us About the Future

RekruttererObservationsstudie
  • UCSF, San Francisco
Alder 18 til 100 · Alle køn · Opdateret 16. dec. 2025 · NCT06039176

AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEM

RekruttererObservationsstudie
  • University of California, San Francisco, San Francisco
  • Kaiser Permanente San Francisco, San Francisco
Alder 22 og opefter · Alle køn · Opdateret 26. mar. 2025 · NCT06378632

Open-label, Dose Escalation Study of Safety and Preliminary Efficacy of TN-401 in Adults With PKP2 Mutation-associated ARVC

RekruttererFase 1
  • University of California San Francisco, San Francisco
Alder 18 til 65 · Alle køn · Opdateret 6. feb. 2025 · NCT06228924

Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction

RekruttererFase 1/2
  • University of California, San Francisco, San Francisco
Alder 18 til 80 · Alle køn · Opdateret 26. mar. 2024 · NCT04703842

Hjertesvigt forsøg i andre byer

Andre studier i San Francisco

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.